{"id":59974,"title":"Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant anemia.","abstract":"","date":"2014-09-06","categories":"Hemic and Lymphatic Diseases","split":"test","url":"http://www.ncbi.nlm.nih.gov/pubmed/25047979","annotations":[{"name":"Myelofibrosis","weight":0.116968,"wikipedia_article":"http://en.wikipedia.org/wiki/Myelofibrosis"},{"name":"Prednisone","weight":0.108635,"wikipedia_article":"http://en.wikipedia.org/wiki/Prednisone"},{"name":"Clinical trial","weight":0.0494293,"wikipedia_article":"http://en.wikipedia.org/wiki/Clinical_trial"},{"name":"Anemia","weight":0.0393397,"wikipedia_article":"http://en.wikipedia.org/wiki/Anemia"},{"name":"Phase (matter)","weight":0.0147415,"wikipedia_article":"http://en.wikipedia.org/wiki/Phase_(matter)"}]}
